Karl-Anton Kreuzer Selected Research

Karl-Anton Kreuzer Research Topics

Disease

23	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2010
14	Neoplasms (Cancer) 01/2021 - 11/2009
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2011 - 01/2002
7	Neutropenia 01/2020 - 03/2014
7	Infections 06/2019 - 03/2002
6	Philadelphia Chromosome 09/2012 - 10/2002
5	Residual Neoplasm 12/2021 - 10/2017
5	Leukemia 04/2016 - 10/2002
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 07/2012
4	Lymphoma (Lymphomas) 04/2016 - 10/2011
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017 - 02/2016
3	Body Weight (Weight, Body) 01/2011 - 01/2004
2	Hemorrhage 01/2022 - 01/2017
2	Pneumonia (Pneumonitis) 01/2022 - 04/2016
2	Exanthema (Rash) 01/2022 - 10/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 04/2003
2	Thrombocytopenia (Thrombopenia) 01/2017 - 04/2016
2	Carcinoma (Carcinomatosis) 03/2009 - 04/2003
1	Myocardial Infarction 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Atrial Fibrillation 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Disease Progression 06/2019
1	Acute Promyelocytic Leukemia 02/2018
1	Cardiotoxicity 01/2018
1	Leukoencephalopathies 10/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2017
1	Febrile Neutropenia 04/2016
1	Refractory Anemia with Excess of Blasts (RAEM) 04/2016
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2016
1	Critical Illness (Critically Ill) 01/2016
1	Myeloid Sarcoma (Chloroma) 06/2014
1	Mycoses (Diseases, Fungus) 02/2014
1	Oral Candidiasis (Thrush) 02/2014

Drug/Important Bio-Agent (IBA)

11	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 01/2002
8	obinutuzumabIBA 01/2022 - 03/2014
7	Bendamustine Hydrochloride FDA Link 01/2022 - 09/2012
7	Rituximab (Mabthera)FDA Link 02/2020 - 09/2012
6	venetoclaxIBA 12/2021 - 01/2018
5	Pharmaceutical PreparationsIBA 01/2022 - 10/2002
5	ibrutinibIBA 01/2022 - 03/2018
4	Tyrosine Kinase InhibitorsIBA 02/2011 - 08/2003
4	Messenger RNA (mRNA)IBA 01/2010 - 08/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2020 - 01/2016
3	fludarabineIBA 02/2020 - 01/2016
3	Chlorambucil (Leukeran)FDA Link 01/2020 - 03/2014
3	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2018 - 06/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 07/2010
3	beta CateninIBA 04/2010 - 03/2009
3	Glycoproteins (Glycoprotein)IBA 11/2009 - 01/2002
2	ofatumumab FDA Link 01/2021 - 03/2018
2	idelalisibIBA 01/2020 - 03/2018
2	Lenalidomide (CC 5013)FDA Link 10/2017 - 09/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2016 - 10/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2015 - 11/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2012 - 07/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2011 - 01/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011 - 01/2011
2	Antineoplastic Agents (Antineoplastics)IBA 10/2011 - 01/2011
2	nitroxy-butyl-acetylsalicylic acidIBA 10/2011 - 01/2011
2	CGP049090IBA 04/2010 - 03/2009
2	bcr-abl Fusion ProteinsIBA 03/2005 - 01/2002
2	Phosphotransferases (Kinase)IBA 03/2005 - 10/2002
2	AcidsIBA 08/2003 - 01/2002
1	AnticoagulantsIBA 01/2022
1	Cytochrome P-450 CYP3AIBA 01/2022
1	pipoxolan (BR 18)IBA 02/2020
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2018
1	AnthracyclinesIBA 02/2018
1	PanobinostatIBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 10/2017
1	Thrombopoietin (c-mpl Ligand)IBA 01/2017
1	Azacitidine (5 Azacytidine)FDA Link 04/2016
1	ON 01910IBA 04/2016
1	Decitabine FDA Link 04/2016
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2016
1	HematinicsIBA 02/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	trichostatin A (A 300)IBA 08/2014
1	Histones (Histone)IBA 08/2014
1	posaconazole FDA Link 02/2014
1	Sorafenib (BAY 43-9006)FDA Link 09/2013
1	DNA (Deoxyribonucleic Acid)IBA 06/2013

Therapy/Procedure

17	Therapeutics 01/2019 - 01/2002
8	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
2	Aftercare (After-Treatment) 01/2018 - 01/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2017 - 02/2016
2	Radiotherapy 06/2014 - 03/2005
2	Stem Cell Transplantation 09/2012 - 10/2011
2	Hematopoietic Stem Cell Mobilization 03/2011 - 10/2003
1	Duration of Therapy 03/2018
1	Erythrocyte Transfusion 02/2016
1	Blood Transfusion (Blood Transfusions) 02/2016
1	Renal Dialysis (Hemodialysis) 01/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2016
1	Critical Care (Surgical Intensive Care) 01/2016
1	Consolidation Chemotherapy 06/2014